Your browser doesn't support javascript.
loading
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
Frankiw, Luke; Singh, Arun; Peters, Cole; Comin-Anduix, Begoña; Berent-Maoz, Beata; Macabali, Mignonette; Shammaie, Kiana; Quiros, Crystal; Kaplan-Lefko, Paula; Baselga Carretero, Ignacio; Ribas, Antoni; Nowicki, Theodore Scott.
Afiliação
  • Frankiw L; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Singh A; Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Peters C; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Berent-Maoz B; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.
  • Macabali M; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Shammaie K; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Quiros C; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Kaplan-Lefko P; Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Baselga Carretero I; Department of Medicine, Division of Pediatric Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Ribas A; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Nowicki TS; Department of Surgery, Division of Surgical Oncology, University of California Los Angeles, Los Angeles, California, USA.
J Immunother Cancer ; 11(5)2023 05.
Article em En | MEDLINE | ID: mdl-37156551
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Melanoma Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Melanoma Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article